HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: results from the Nutrient Gene Interactions in Human Obesity: implications for dietary guidelines (NUGENOB) randomized trial.

Abstract
Background: Circulating branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) have been shown to be associated with insulin resistance and diabetes risk. The common rs1440581 T allele in the protein phosphatase Mg2+/Mn2+ dependent 1K (PPM1K) gene has been related to elevated BCAA concentrations and risk of type 2 diabetes.Objective: In the present study, we tested whether dietary fat and carbohydrate intakes influenced the association between the rs1440581 PPM1K genetic variant and glucose-metabolism traits during weight loss.Design: The rs1440581 PPM1K genetic variant was genotyped in a total of 757 nondiabetic individuals who were randomly assigned to 1 of 2 energy-restricted diets that differed in macronutrient composition (low-fat diet: 20-25% fat, 15% protein, and 60-65% carbohydrate; high-fat diet: 40-45% fat, 15% protein, and 40-45% carbohydrate). The changes in fasting glucose, fasting insulin, insulin resistance (homeostasis model assessment of insulin resistance) and homeostasis model assessment of β cell function (HOMA-B) were measured after a mean ± SD weight loss of 6.8 ± 3.4 kg over 10 wk and analyzed according to the presence of the T allele of rs1440581.Results: The rs1440581 T allele was associated with a smaller improvement in glucose concentrations after the 10-wk dietary intervention (β ± SE: 0.05 ± 0.02 mg/dL; P = 0.03). In addition, significant gene-diet interactions were shown for the rs1440581 PPM1K genetic variant in relation to changes in insulin and HOMA-B (P-interaction = 0.006 and 0.002, respectively). In response to the high-fat diet, the T allele was associated with a higher reduction of insulin (β ± SE: -0.77 ± 0.40 μU/mL; P = 0.04) and HOMA-B (β ± SE: -13.2 ± 3.81; P = 0.003). An opposite effect was observed in the low-fat diet group, although in this group the T allele was marginally (P = 0.10) and not significantly (P = 0.24) associated with insulin and HOMA-B, respectively.Conclusion:PPM1K rs1440581 may affect changes in glucose metabolism during weight loss, and this effect is dependent on dietary fat and carbohydrate intakes. This trial was registered at controlled-trials.com as ISRCTN25867281.
AuthorsLeticia Goni, Lu Qi, Marta Cuervo, Fermín I Milagro, Wim H Saris, Ian A MacDonald, Dominique Langin, Arne Astrup, Peter Arner, Jean-Michel Oppert, Mathilde Svendstrup, Ellen E Blaak, Thorkild Ia Sørensen, Torben Hansen, J Alfredo Martínez
JournalThe American journal of clinical nutrition (Am J Clin Nutr) Vol. 106 Issue 3 Pg. 902-908 (Sep 2017) ISSN: 1938-3207 [Electronic] United States
PMID28768654 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© 2017 American Society for Nutrition.
Chemical References
  • Amino Acids, Branched-Chain
  • Blood Glucose
  • Dietary Carbohydrates
  • Dietary Fats
  • Insulin
  • PPM1K protein, human
  • Protein Phosphatase 2C
Topics
  • Adult
  • Amino Acids, Branched-Chain
  • Blood Glucose (metabolism)
  • Diabetes Mellitus, Type 2 (blood, etiology, genetics)
  • Diet
  • Dietary Carbohydrates (administration & dosage, pharmacology)
  • Dietary Fats (administration & dosage, pharmacology)
  • Feeding Behavior
  • Female
  • Gene-Environment Interaction
  • Genotype
  • Humans
  • Insulin (blood)
  • Insulin Resistance (genetics)
  • Insulin-Secreting Cells
  • Male
  • Middle Aged
  • Obesity (blood, complications, diet therapy, genetics)
  • Polymorphism, Single Nucleotide
  • Protein Phosphatase 2C (genetics)
  • Weight Loss (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: